NCT01636531View on ClinicalTrials.gov

A Study of A High Concentration Liquid Formulation Versus A Lyophilized Formulation of Gantenerumab in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

October 31, 2012

Study Completion Date

October 31, 2012

Conditions
Healthy Volunteer
Interventions
DRUG

gantenerumab

High concentration liquid formulation (HCLF), single dose sc

DRUG

gantenerumab

Lyophilized formulation (LyoF), single dose sc

Trial Locations (1)

35042

Rennes

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01636531 - A Study of A High Concentration Liquid Formulation Versus A Lyophilized Formulation of Gantenerumab in Healthy Volunteers | Biotech Hunter | Biotech Hunter